CT肺气肿亚型一年进展可预测肺功能下降:SPIROMICS研究
SPIROMICS队列纳入880名吸烟者及对照,分析第1至2次访视间定量CT肺气肿亚型的一年变化与后续FEV₁下降的关系。结果显示,支气管炎-尖段肺气肿(CBaE)和弥漫性肺气肿每增加1个标准差,FEV₁年下降分别加速4.2 mL/年和6.2 mL/年,且独立于标准QCT指标。
要点
- CT肺气肿亚型一年进展可预测后续FEV₁加速下降
- CBaE和弥漫性肺气肿的预测作用独立于标准QCT指标
- 支持将CT肺气肿亚型作为COPD临床试验的中间终点
核心结论
- CT肺气肿亚型的一年进展可预测FEV₁加速下降,支持其作为COPD试验的潜在中间终点。
研究设计与样本
- SPIROMICS队列研究,纳入880名≥20包年吸烟者(伴或不伴COPD)及非吸烟对照,完成四次年度访视和第五次访视。
- 分析第1和第2次访视的胸部CT,评估机器学习CT肺气肿亚型(CBaE、弥漫性肺气肿)及标准QCT指标的一年变化。
- 采用线性混合效应模型评估一年QCT变化与第2至5次访视期间FEV₁下降的关联。
主要发现
- 880名参与者中,FEV₁平均年下降-30.4 mL/年(95% CI: -34.5, -26.3)。
- CBaE和弥漫性肺气肿每增加1个标准差(SD)的一年进展,分别预测FEV₁年下降加速-4.2 mL/年(95% CI: -8.3, -0.2)和-6.2 mL/年(95% CI: -10.7, -1.8)。
- 标准QCT肺气肿指标变化也预测FEV₁下降,但多指标同时纳入时仅CBaE和弥漫性肺气肿保持独立预测作用。
临床怎么用
- 在COPD临床试验中,可考虑将CT肺气肿亚型(CBaE和弥漫性肺气肿)的一年进展作为预测肺功能下降的中间终点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: Intermediate endpoints that predict lung function decline are needed to improve the efficiency of clinical trials in chronic obstructive pulmonary disease (COPD). OBJECTIVES: To test if one-year progression of quantitative computed tomography (QCT) measures predicts subsequent FEV₁ decline. METHODS: SPIROMICS recruited individuals with ≥ 20 pack-years smoking history with or without COPD and nonsmoking controls who underwent four annual and a later fifth visit. We analyzed chest CT scans at visits one and two for machine-learned CT emphysema subtypes (combined bronchitic-apical emphysema [CBaE], diffuse emphysema) and standard QCT measures of emphysema (percent emphysema-950HU, 15th percentile HU, volume-adjusted lung density), airways, functional small airways, hyperinflation, parenchymal texture and vasculature. Linear mixed-effects models evaluated associations between one-year QCT measure changes and FEV₁ decline from visits two through five, adjusting for demographics, site, enrollment group, baseline QCT value, and time-varying anthropometrics and smoking. MEASUREMENTS AND MAIN RESULTS: Among 880 participants (43% mild/moderate COPD, 17% severe COPD, 29% smoking controls, 11% nonsmoking controls), FEV₁ declined -30.4mL/year (95% CI: -34.5, -26.3). A standard deviation (SD) one-year increase in CBaE and diffuse emphysema predicted an accelerated decline in FEV1 of - 4.2 mL/year (95% CI: -8.3, -0.2) and -6.2 mL/year (95% CI: -10.7, -1.8), respectively. Changes in standard QCT emphysema measures also predicted change in FEV1 decline, but only CBaE and diffuse emphysema remained independently predictive of accelerated FEV1 decline when all were considered together. CONCLUSIONS: One-year progression of CT emphysema subtypes predicted accelerated FEV₁ decline, supporting their potential use as intermediate endpoints in COPD trials.
引用
- Hermann EA, Hoffman EA, Angelini ED, et al. One-year progression of CT emphysema subtypes predict lung function decline: SPIROMICS. Am J Respir Crit Care Med. 2026. PMID: 42788667. doi:10.1093/ajrccm/aamag497
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。